Review paper: Implications of the "cancer stem cell" hypothesis on murine models of colon cancer and colitis-associated cancer

Veterinary Pathology

Volumn 46, Issue 5, 2009, Pages 819-835

  Hynes, M J ^a   Huang, K M ^b   Huang, E H ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Cancer stem cells; Colitis; Murine models

Indexed keywords

ANIMAL; ARTICLE; CANCER STEM CELL; COLITIS; COLON TUMOR; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; MOUSE;

ANIMALS; COLITIS; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; INFLAMMATION; MICE; NEOPLASTIC STEM CELLS;

MURINAE;

EID: 77149176657     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.08-VP-0172-H-REV     Document Type: Article

References (98)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988, 2003
2. Amann M, Brischwein K, Lutterbuese P, Parr L, Petersen L, Lorenczewski G, Krinner E, Bruckmeier S, Lippold S, Kischel R, Lutterbuese R, Kufer P, Baeuerle PA, Schlereth B: Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3. Cancer Res 68:143-151, 2008
3. Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM: Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/2 compound mutant mice. Nat Genet 35:323-330, 2003
4. Armstrong L, Stojkovic M, Dimmick I, Ahmad S, Stojkovic P, Hole N, Lako M: Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 22:1142-1151, 2004
5. Autschbach F, Giese T, Gassler N, Sido B, Heuschen G, Heuschen U, Zuna I, Schulz P, Weckauf H, Berger I, Otto HF, Meuer SC: Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch 441:500-513, 2002
6. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217-221, 1989
7. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JK, Hamilton S, Vogelstein B: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717-7722, 1990
8. Barker N, Clevers H: Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology 133:1755-1760, 2007
9. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H: Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003-1007, 2007
10. Becher OJ, Holland EC: Genetically engineered models have advantages over xenografts for preclinical studies. Cancer Res 66: 3355-3358, discussion 3358-3359, 2006
11. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D: Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98:1010-1020, 1996
12. Bernstein CN: A balancing view: Dysplasia surveillance in ulcerative colitis-sorting the pro from the con. Am J Gastroenterol 99:1636-1637, 2004
13. Bernstein CN: Neoplasia in inflammatory bowel disease: surveillance and management strategies. Curr Gastroenterol Rep 8:513-518, 2006
14. Bernstein CN, Shanahan F, Weinstein WM: Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343:71-74, 1994
15. Biasco G, Derenzini E, Grazi G, Ercolani G, Ravaioli M, Pantaleo MA, Brandi G: Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 32:214-228, 2006
16. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitivehematopoieticcell. Nat Med 3:730-737, 1997
17. Bos JL, Fearon ER, Hamilton SR, Verlaan-DeVries M, van Boom JH, van der Eb AJ, Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327:293-297, 1987
18. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA: The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 26:1513-1519, 2005
19. Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ, McDonnell DP: Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 103:11707-11712, 2006
20. Clevers H: Wnt breakers in colon cancer. Cancer Cell 5:5-6, 2004
21. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946-10951,2005
22. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, Strazzer S, Bresolin N, Comi GP: Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 24:975-985, 2006
23. Coussens LM, Werb Z: Inflammation and cancer. Nature 420:860-867, 2002
24. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104:10158-10163, 2007
25. De Wever O, Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol 200:429-447, 2003
26. Dekker E, van den Broek FJ, Reitsma JB, Hardwick JC, Offerhaus GJ, van Deventer SJ, Hommes DW, Fockens P: Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 39:216-221, 2007
27. Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659, 1986
28. Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48:526-535, 2001
29. Farkas S, Hornung M, Sattler C, Anthuber M, Gunthert U, Herfarth H, Schlitt HJ, Geissler EK, Wittig BM: Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 142:260-267, 2005
30. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
31. Fidler IJ: Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 10:229-243, 1991
32. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, Breukel C, Alt E, Lipkin M, Khan PM, Kucherlapati R: A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 91:8969-8973, 1994
33. Fu XY, Besterman JM, Monosov A, Hoffman RM: Models of human metastatic colon cancer in nudemice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci USA 88:9345-9349, 1991
34. Furukawa T, Kubota T, Watanabe M, Ku TH, Nishibori H, Kase S, Saikawa Y, Tanino H, Teramoto T, Ishibiki K, Kitajima M: A metastatic model of human colon cancer constructed using cecal implantation of cancer tissue in nude mice. Surg Today 23:420-423, 1993
35. Giavazzi R, Campbell DE, Jessup JM, Cleary K, Fidler IJ: Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res 46:1928-1933, 1986
36. Goodison S, Urquidi V, Tarin D: CD44 cell adhesion molecules. Mol Pathol 52:189-196, 1999
37. Goss KH, Risinger MA, Kordich JJ, Sanz MM, Straughen JE, Slovek LE, Capobianco AJ, German J, Boivin GP, Groden J: Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297:2051-2053, 2002
38. Green JE, Hudson T: The promise of genetically engineered mice for cancer prevention studies. Nat Rev Cancer 5:184-198, 2005
39. Grosser T, Fries S, FitzGerald GA: Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116:4-15, 2006
40. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70, 2000
41. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, Wiedemann LM, Mishina Y, Li L: BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 36: 1117-1121, 2004
42. Heijstek MW, Kranenburg O, Borel Rinkes IH: Mouse models of colorectal cancer and liver metastases. Dig Surg 22:16-25, 2005
43. Heldin CH, Miyazono K, ten Dijke P: TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471, 1997
44. Herman P, Huber S, Harrier T, Aicher A, Ellwart J, Guba M, Bruns C, Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 3:313-323, 2007
45. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC: Gastric cancer originating from bone marrow-derived cells. Science 306:1568-1571, 2004
46. Houghton J, Wang TC: Helicobacter pylori and gastric cancer: a new paradigm for inflammationassociated epithelial cancers. Gastroenterology 128: 1567-1578, 2005
47. Itzkowitz SH, Yio X: Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7-17, 2004
48. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
49. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE: Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12:1167-1174, 2006
50. Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, Sausville EA: Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84:1424-1431, 2001
51. Kim KM, Calabrese P, Tavare S, Shibata D: Enhanced stem cell survival in familial adenomatous polyposis. Am J Pathol 164:1369-1377, 2004
52. Kim KM, Shibata D: Methylation reveals a niche: stem cell succession in human colon crypts. Oncogene 21:5441-5449, 2002
53. Kitano A, Oshitani N, Matsumoto T, Kobayashi K: CD44 variants in ulcerative colitis and Crohn's disease. Lancet 348:266-267, 1996
54. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274, 1993
55. Kuper H, Adami HO, Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med 248:171-183, 2000
56. Le NH, Franken P, Fodde R: Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness. Br J Cancer 98:1886-1893, 2008
57. Leedham SJ, Wright NA: Expansion of a mutated clone: from stem cell to tumour. J Clin Pathol 61:164-171, 2008
58. Leow CC, Polakis P, Gao WQ: A role for Hath1, a bHLH transcription factor, in colon adenocarcinoma. Ann N Y Acad Sci 1059:174-183, 2005
59. Leow CC, Romero MS, Ross S, Polakis P, Gao WQ:Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res 64:6050-6057, 2004
60. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 67:1030-1037, 2007
61. Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F, Fleuren GJ, Warnaar SO: Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 139:1337-1348, 1997
62. Loeffler M, Potten CS, Paulus U, Glatzer J, Chwalinski S: Intestinal crypt proliferation. II. Computer modelling of mitotic index data provides further evidence for lateral and vertical cell migration in the absence of mitotic activity. Cell Tissue Kinet 21:247-258, 1988
63. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR: Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 46:336-343, 2000
64. Luo G, Santoro IM, McDaniel LD, Nishijima I, Mills M, Youssoufian H, Vogel H, Schultz RA, Bradley A: Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 26:424-429, 2000
65. Mahler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, Elson CO, Sundberg JP: Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274:G544-551, 1998
66. Mahler M, Leiter EH: Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. Inflamm Bowel Dis 8:347-355,2002
67. Marhaba R, Zoller M: CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35:211-231, 2004
68. Matsumoto T, Iwao Y, Igarashi M, Watanabe K, Otsuka K, Watanabe T, Iizuka B, Hida N, Sada M, Chiba T, Kudo SE, Oshitani N, Nagawa H, Ajioka Y, Hibi T: Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. Inflamm Bowel Dis 14:259-264, 2008
69. McCormack G, Moriarty D, O'Donoghue DP, McCormick PA, Sheahan K, Baird AW: Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 50:491-495, 2001
70. Moser AR, Pitot HC, Dove WF: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-324, 1990
71. Mudter J, Neurath MF: Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 13:1016-1023, 2007
72. Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV: Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol 18:260-267, 2008
73. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110, 2007
74. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606, 2001
75. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM: Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803-809, 1996
76. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M: Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 92:4482-4486, 1995
77. Oshima Y, Suzuki A, Kawashimo K, Ishikawa M, Ohkohchi N, Taniguchi H: Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting. Gastroenterology 132:720-732, 2007
78. Ponta H, Sherman L, Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33-45, 2003
79. Potten CS, Hendry JH, Moore JV: Estimates of the number of clonogenic cells in crypts of murine small intestine. Virchows Arch B Cell Pathol Incl Mol Pathol 53:227-234, 1987
80. Potten CS, Kellett M, Rew DA, Roberts SA: Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli. Gut 33:524-529, 1992
81. Potten CS, Loeffler M: Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110:1001-1020, 1990
82. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW: APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237, 1992
83. Prochazka M, Gaskins HR, Shultz LD, Leiter EH: The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 89:3290-3294, 1992
84. Renehan AG, O'Dwyer ST, Haboubi NJ, Potten CS: Early cellular events in colorectal carcinogenesis. Colorectal Dis 4:76-89, 2002
85. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115, 2007
86. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT: CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117:3539-3545, 2004
87. Rygaard J, Povlsen CO: Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol Microbiol Scand 77:758-760, 1969
88. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D, Rafii S: CD133 expression is not restricted to stem cells, and both CD133+ and CD1332 metastatic colon cancer cells initiate tumors. J Clin Invest 118:2111-2120, 2008
89. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828, 2003
90. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 432:396-401, 2004
91. Strober W, Fuss IJ, Blumberg RS: The immunology of mucosal models of inflammation. Annu Rev Immunol 20:495-549, 2002
92. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H: Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351:820-824, 2006
93. Toole BP, Slomiany MG: Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol 18:244-250, 2008
94. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL: Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97:14720-14725, 2000
95. Wicha MS, Liu S, Dontu G: Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66:1883-1890, discussion 1895-1886, 2006
96. Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM: Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94:1402-1407, 1997
97. Winter MJ, Nagtegaal ID, van Krieken JH, Litvinov SV: The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 163:2139-2148,2003
98. Zeilstra J, Joosten SP, Dokter M, Verwiel E, Spaargaren M, Pals ST: Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. Cancer Res 68:3655-3661, 2008